Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,227Revenue $M85.6Net Margin (%)-74.7Z-Score7.0
Enterprise Value $M2,254EPS $-1.9Operating Margin %-62.3F-Score4
P/E(ttm))0Cash Flow Per Share $-2.0Pre-tax Margin (%)-75.2Higher ROA y-yN
Price/Book53.710-y EBITDA Growth Rate %0Quick Ratio6.6Cash flow > EarningsY
Price/Sales25.65-y EBITDA Growth Rate %-62.2Current Ratio7.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-37.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-154.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M33.3ROI % (ttm)-53.4Gross Margin Increase y-yY

Gurus Latest Trades with PCRX

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PCRXMariko Gordon 2013-12-31 Add2.08%$47.74 - $56.97
($52.53)
$ 66.0526%Add 203.52%1,304,190
PCRXRon Baron 2013-12-31 Buy $47.74 - $56.97
($52.53)
$ 66.0526%New holding, 6495 sh.6,495
PCRXMariko Gordon 2013-09-30 Add0.93%$30.01 - $47.47
($36.37)
$ 66.0582%Add 3812.66%429,688
PCRXMariko Gordon 2013-06-30 Buy 0.02%$25.84 - $30.26
($28.93)
$ 66.05128%New holding, 10982 sh.10,982
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PCRX Ron Baron 2013-12-316,4950.020New Buy
PCRX Mariko Gordon 2013-12-311,304,1903.913.1+203.52%
Premium Most recent portfolio changes are included for Premium Members only!


PCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LONGENECKER JOHN P PHDDirector 2014-03-28Sell1,000$64.634.78view
Wicki AndreasDirector 2014-03-06Sell24,887$80.16-15.52view
Scibetta James SCFO 2013-12-30Sell10,000$55.5521.91view
LONGENECKER JOHN P PHDDirector 2013-12-30Sell2,500$55.5521.91view
STACK DAVID MPresident and CEO 2013-12-30Sell15,000$55.8421.28view
Markvicka TauniaVice President, Commercial 2013-11-06Sell50,000$51.1432.42view
PATOU GARYChief Medical Officer 2013-10-01Sell20,000$48.9238.43view
STACK DAVID MPresident and CEO 2013-09-30Sell15,000$47.0543.93view
Scibetta James SCFO 2013-09-30Sell10,000$46.7444.89view
LONGENECKER JOHN P PHDDirector 2013-09-30Sell2,500$46.7444.89view

Press Releases about PCRX :

Quarterly/Annual Reports about PCRX:

News about PCRX:

Articles On GuruFocus.com
Baron Funds Comments on Pacira Pharmaceuticals Mar 05 2014 
comment on PCRX Mar 15 2013 
Weekly CFO Buys Highlight: PCRX, UGI, MIG, GLT, IOSP Feb 27 2011 
Weekly CFO Buys Highlight: REFR, UGI, PCRX, NOIZ Feb 21 2011 
Pacira Pharmaceuticals Inc. (PCRX) CFO James S Scibetta buys 5,000 Shares Feb 16 2011 
Pacira Pharmaceuticals Inc. (PCRX) CEO David M Stack buys 5,000 Shares Feb 11 2011 

More From Our Partners
Pacira Prices Offering, Shares Soar - Analyst Blog Apr 10 2014 - ZACKS

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide